Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-09-05

Clinical Trial Update: Pediatric Diabetics Type 1 Using InsuPatch [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating InsuPatch in pediatric Type 1 diabetes patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • InsuPatch

Snippet

Sponsor: Insuline Medical Ltd. | Conditions: Type 1 Diabetes Mellitus | Phase 3 | Status: COMPLETED